Russian plans for rebuilding its pharmaceutical sector

Russia plans to rebuild its pharmaceutical sector, which has been hit significantly by international sanctions and their consequences, that will be part of the recently announced state strategy of ensuring Russia’s national drug sovereignty by reducing the country’s dependence on the imports at all stages of drug production, from intermediates to the production of pharmaceutical substances.

As part of these plans, is launching the production of most of drugs on the list of vital and essential within the territory of the country.

Currently, only 379 out of 808 drugs from the list of Vital and Essential Medicines are produced in Russia. Given the new reality, Russia is forced to look for new ways to solve the problem.